View in EDS

Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Saved in:
Bibliographic Details
Title: Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Authors: Dvorak CC; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California. Electronic address: Christopher.dvorak@ucsf.edu., Waters E; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Temple WC; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Salinas Cisneros G; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Chu J; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Winestone LE; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Higham CS; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Kharbanda S; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Shimano KA; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Avagyan S; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California., Pauerstein P; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California; Division of Pediatric Oncology, University of California San Francisco, San Francisco, California., Huang JN; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California; Division of Pediatric Hematology, University of California San Francisco, San Francisco, California., Brooks JT; InsightRx, San Francisco, California., Long-Boyle JR; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2026 Apr; Vol. 32 (4), pp. 476.e1-476.e14. Date of Electronic Publication: 2025 Dec 07.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41365398
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dvorak+CC%22">Dvorak CC</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California. Electronic address: Christopher.dvorak@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Waters+E%22">Waters E</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Temple+WC%22">Temple WC</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Salinas+Cisneros+G%22">Salinas Cisneros G</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Chu+J%22">Chu J</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Winestone+LE%22">Winestone LE</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Higham+CS%22">Higham CS</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Kharbanda+S%22">Kharbanda S</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Shimano+KA%22">Shimano KA</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Avagyan+S%22">Avagyan S</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Pauerstein+P%22">Pauerstein P</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California; Division of Pediatric Oncology, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Huang+JN%22">Huang JN</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California; Division of Pediatric Hematology, University of California San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Brooks+JT%22">Brooks JT</searchLink>; InsightRx, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Long-Boyle+JR%22">Long-Boyle JR</searchLink>; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, San Francisco, California; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2026 Apr; Vol. 32 (4), pp. 476.e1-476.e14. <i>Date of Electronic Publication: </i>2025 Dec 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41365398
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtct.2025.12.007
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 476.e1-476.e14
    Titles:
      – TitleFull: Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dvorak CC
      – PersonEntity:
          Name:
            NameFull: Waters E
      – PersonEntity:
          Name:
            NameFull: Temple WC
      – PersonEntity:
          Name:
            NameFull: Salinas Cisneros G
      – PersonEntity:
          Name:
            NameFull: Chu J
      – PersonEntity:
          Name:
            NameFull: Winestone LE
      – PersonEntity:
          Name:
            NameFull: Higham CS
      – PersonEntity:
          Name:
            NameFull: Kharbanda S
      – PersonEntity:
          Name:
            NameFull: Shimano KA
      – PersonEntity:
          Name:
            NameFull: Avagyan S
      – PersonEntity:
          Name:
            NameFull: Pauerstein P
      – PersonEntity:
          Name:
            NameFull: Huang JN
      – PersonEntity:
          Name:
            NameFull: Brooks JT
      – PersonEntity:
          Name:
            NameFull: Long-Boyle JR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6367
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Transplantation and cellular therapy
              Type: main
ResultId 1